New Key Statistics Module, Z-Score and F-Score
OTCPK:ZLDAF Key Ratios
| Market Cap $ M | 4.80 |
| Enterprise Value $ M | 8.29 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 70.55 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -2.16 |
| Beneish M-Score | -593.96 |
| 10-y EBITDA Growth Rate % | -6.90 |
| 5-y EBITDA Growth Rate % | -9.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.35 |
| EV-to-EBITDA | -0.35 |
| PEG | -- |
| Shares Outstanding M | 11.35 |
| Net Margin (%) | -38,493.68 |
| Operating Margin % | -6,250.53 |
| Pre-tax Margin (%) | -38,673.68 |
| Quick Ratio | 0.42 |
| Current Ratio | 0.60 |
| ROA % (ttm) | -259.34 |
| ROE % (ttm) | -439.78 |
| ROIC % (ttm) | -45.13 |
| Dividend Yield % | -- |
| Altman Z-Score | -45.05 |
ZLDAF Number of Guru Trades
ZLDAF Volume of Guru Trades
Gurus Latest Trades with OTCPK:ZLDAF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ZLDAF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zelira Therapeutics Ltd Insider Transactions
No Available Data
News about OTCPK:ZLDAF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers